Enovix/$ENVX
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Enovix
Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.
- Ticker
- $ENVX
- Sector
- Industrials
- Primary listing
- NASDAQ
- Employees
- 664
- Headquarters
- Fremont, United States
- Website
- www.enovix.com
Enovix Metrics
BasicAdvanced
$674M
-
-$0.79
2.30
-
Price and volume
Market cap
$674M
Beta
2.3
52-week high
$12.40
52-week low
$2.20
Average daily volume
9.8M
Financial strength
Current ratio
9.705
Quick ratio
9.19
Long term debt to equity
2.485
Total debt to equity
2.535
Interest coverage (TTM)
-5.70%
Profitability
EBITDA (TTM)
-140.911
Gross margin (TTM)
18.83%
Net profit margin (TTM)
-473.89%
Operating margin (TTM)
-503.82%
Effective tax rate (TTM)
0.50%
Revenue per employee (TTM)
$50,000
Management effectiveness
Return on assets (TTM)
-17.55%
Return on equity (TTM)
-81.28%
Valuation
Price to revenue (TTM)
18.836
Price to book
3.21
Price to tangible book (TTM)
3.99
Price to free cash flow (TTM)
-5.441
Free cash flow yield (TTM)
-18.38%
Free cash flow per share (TTM)
-0.579
Growth
Revenue change (TTM)
34.88%
Earnings per share change (TTM)
22.29%
3-year revenue growth (CAGR)
213.54%
3-year earnings per share growth (CAGR)
-18.98%
What the Analysts think about Enovix
Analyst ratings (Buy, Hold, Sell) for Enovix stock.
Analyst projections of the future price of Enovix stock.
Bulls say / Bears say
Preliminary Q3 revenue rose 38% year on year to $11 million, above guidance, extending Enovix’s run of year-on-year growth to six quarters. That points to commercial activity starting to build, even though sales remain small. (Enovix)
Demand from drone and defence customers is gaining traction: they made up about 70% of Q3 revenue, while the company’s related pipeline grew to $216 million. Enovix says early Q4 orders already exceeded Q3 revenue and plans to spend $19 million to double capacity at its established South Korean plant. (Enovix)
Enovix has moved beyond testing into initial smart-eyewear sales, with key safety certifications completed and a customer order for 50,000 battery packs in 2026. It shipped about 2,100 in Q2 and expected a much larger Q3 delivery, offering an early test of whether its silicon-anode cells can scale commercially. (Enovix)
Smartphone sales still depend on customer qualification: the lead customer’s final accelerated cycle-life test was under way in Q2, with system-level testing to follow, while a second OEM had yet to start receiving samples. Any delay or failure could defer a potentially important growth driver. (Enovix)
Manufacturing scale remains unproven at the key Malaysian line. Zone 1 dicing yield was about 84% in Q2, and Enovix still expected several important mechanical dicing steps to come online only around year-end, leaving throughput and cost targets dependent on execution. (Enovix)
The company remains loss-making and cash-hungry: preliminary Q3 operating loss was about $39 million, against just $11 million of revenue, and cash was about $512 million in early October versus $552 million at the end of Q2. Continued investment in capacity and operations could consume that sizeable reserve before the business becomes self-funding. (Enovix, Enovix)
Data summarised monthly by Lightyear AI. Last updated on 23 Oct 2026.
Enovix Financial Performance
Revenues and expenses
Enovix Earnings Performance
Company profitability
Upcoming events
No upcoming events
Enovix News
AllArticlesVideos
Funds containing Enovix
AllUSDEURGBP
Fund name | Fund size | $ENVX weighting |
|---|---|---|
iShares Lithium & Battery Producers£LITM | $73M | 0.54% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.02% |
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.02% |
iShares MSCI World Small Cap£WLDS | $9B | 0.01% |
iShares MSCI World Small Cap€IUSN | $9B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.